Epsilon Healthcare Ltd Asset Resilience Ratio
Epsilon Healthcare Ltd asset resilience ratio. Epsilon Healthcare Ltd (EPN) has an Asset Resilience Ratio of 1.69% as of June 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See EPN defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Epsilon Healthcare Ltd (2016–2019)
Asset resilience ratio of Epsilon Healthcare Ltd from 2016 to 2019. This chart shows how Epsilon Healthcare Ltd's Asset Resilience Ratio has changed over time. Read Epsilon Healthcare Ltd total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Epsilon Healthcare Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see EPN total assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$301.46K | 1.69% |
| Short-term Investments | AU$0.00 | 0% |
| Total Liquid Assets | AU$301.46K | 1.69% |
Asset Resilience Insights
- Limited Liquidity: Epsilon Healthcare Ltd maintains only 1.69% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Epsilon Healthcare Ltd Industry Peers by Asset Resilience Ratio
Compare Epsilon Healthcare Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2 |
Drug Manufacturers - Specialty & Generic | 0.20% |
|
Changchun High & New Technology Industries Group Inc
SHE:000661 |
Drug Manufacturers - Specialty & Generic | 5.50% |
|
Chengdu Kanghong Pharmaceuticals Group Co Ltd
SHE:002773 |
Drug Manufacturers - Specialty & Generic | 29.37% |
|
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267 |
Drug Manufacturers - Specialty & Generic | 0.01% |
|
Shenzhen Chipscreen Biosciences Co
SHG:688321 |
Drug Manufacturers - Specialty & Generic | 5.10% |
|
Cronos Group Inc
TO:CRON |
Drug Manufacturers - Specialty & Generic | 69.94% |
|
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557 |
Drug Manufacturers - Specialty & Generic | 0.29% |
|
HPGC Renmintongtai Pharmaceutical Corp
SHG:600829 |
Drug Manufacturers - Specialty & Generic | 0.00% |
Epsilon Healthcare Ltd Asset Resilience Ratio by Year (2016–2019)
Epsilon Healthcare Ltd asset resilience ratio by year from 2016 to 2019. The table below shows the annual Asset Resilience Ratio data for Epsilon Healthcare Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2019-12-31 | 12.77% | AU$3.55 Million ≈ $2.51 Million |
AU$27.81 Million ≈ $19.68 Million |
-6.57pp |
| 2018-12-31 | 19.34% | AU$6.33 Million ≈ $4.48 Million |
AU$32.75 Million ≈ $23.17 Million |
-30.95pp |
| 2017-12-31 | 50.29% | AU$11.04 Million ≈ $7.81 Million |
AU$21.95 Million ≈ $15.53 Million |
+42.57pp |
| 2016-12-31 | 7.73% | AU$885.37K ≈ $626.46K |
AU$11.46 Million ≈ $8.11 Million |
-- |
About Epsilon Healthcare Ltd
Epsilon Healthcare Limited, together with its subsidiaries, engages in the healthcare business in Australia. The company operates in three segments, Contract Development and Manufacturing Activities, Telehealth Medical Practice Services, and Pharmacy Services. It is involved in the healthcare and clinics operation; pharmaceutical contract development and manufacturing; development and manufacturi… Read more